Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinically relevant pharmacogenetic markers in Tatars and Balkars.
Abdullaev SP, Mirzaev KB, Burashnikova IS, Shikaleva AA, Kachanova AA, Abdullaev SP, Akmalova KA, Sozaeva ZA, Grishina EA, Sozaeva MS, Rytkin EI, Sychev DA. Abdullaev SP, et al. Among authors: sychev da. Mol Biol Rep. 2020 May;47(5):3377-3387. doi: 10.1007/s11033-020-05416-4. Epub 2020 Apr 17. Mol Biol Rep. 2020. PMID: 32303955
Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.
Sychev DA, Zastrozhin MS, Miroshnichenko II, Baymeeva NV, Smirnov VV, Grishina EA, Ryzhikova KA, Mirzaev KB, Markov DD, Skryabin VY, Snalina NE, Nosikova PG, Savchenko LM, Bryun EA. Sychev DA, et al. Drug Metab Pers Ther. 2017 Sep 26;32(3):129-136. doi: 10.1515/dmpt-2017-0021. Drug Metab Pers Ther. 2017. PMID: 28787271
Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.
Zastrozhin MS, Antonenko AP, Nesterenko EV, Seyfullaeva LI, Mustafina VR, Esakova AP, Grishina EA, Sorokin AS, Skryabin VY, Savchenko LM, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: sychev da. Drug Metab Pers Ther. 2018 Dec 19;33(4):187-194. doi: 10.1515/dmpt-2018-0019. Drug Metab Pers Ther. 2018. PMID: 30325732
Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.
Zastrozhin MS, Sorokin AS, Agibalova TV, Grishina EA, Antonenko AР, Rozochkin IN, Duzhev DV, Skryabin VY, Galaktionova TE, Barna IV, Orlova AV, Aguzarov AD, Savchenko LM, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: sychev da. Hum Psychopharmacol. 2018 Nov;33(6):e2677. doi: 10.1002/hup.2677. Epub 2018 Oct 25. Hum Psychopharmacol. 2018. PMID: 30357930
Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis.
Sychev DA, Abdullaev SP, Mirzaev KB, Ryzhikova KA, Shuyev GN, Sozaeva ZA, Grishina EA, Mammaev SN, Gafurov DM, Kitaeva EY, Shprakh VV, Suleymanov SS, Bolieva LZ, Sozaeva MS, Zhuchkova SM, Gimaldinova NE, Sidukova EE, Asoskova AV, Mumladze RB. Sychev DA, et al. Mol Biol Rep. 2019 Jun;46(3):2761-2769. doi: 10.1007/s11033-019-04722-w. Epub 2019 Mar 8. Mol Biol Rep. 2019. PMID: 30850966
ADME pharmacogenetics: future outlook for Russia.
Mirzaev KB, Fedorinov DS, Ivashchenko DV, Sychev DA. Mirzaev KB, et al. Among authors: sychev da. Pharmacogenomics. 2019 Jul;20(11):847-865. doi: 10.2217/pgs-2019-0013. Epub 2019 Aug 1. Pharmacogenomics. 2019. PMID: 31368406
Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder.
Zastrozhin MS, Skryabin VY, Torrado M, Petrovna A, Sorokin AS, Grishina EA, Ryzhikova KA, Bedina IA, Buzik OZ, Chumakov EM, Savchenko LM, Brun EA, Sychev DA. Zastrozhin MS, et al. Among authors: sychev da. Pharmacogenomics. 2020 Jan;21(2):111-123. doi: 10.2217/pgs-2019-0019. Pharmacogenomics. 2020. PMID: 31957548
161 results